Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.

Institute of Genetics and Cancer

Institute of Genetics and Cancer

A blog for our community to write about their interests and to share their stories.

Paget’s Awareness Day

Diagramme of Paget's disease of the bone with symptoms

Paget’s Awareness Day is held annually on 11 January and this year’s focus is on pain – one of the most significant aspects of Paget’s disease.

Researchers at the Institute of Genetics and Cancer have found that in Paget’s disease of bone (PDB) there is abnormal processing of sensory signals, but this only applies to the skin overlying bones that are affected by the disease.

This was discovered in a study of 156 people with PDB from all over the UK who took part in the Pain in Paget’s disease  (Pip) study.

As part of this study, a technique called ‘Quantitative sensory testing’ (QST)  was used to measure processing of sensory signals including pain, fine touch, vibration, and hot and cold, in people with PDB.

The signals were studied in the skin close to areas of affected bone as well as ‘control’ areas where there was no evidence of Paget’s disease underlying the area tested.

Professor Stuart Ralston, who led the research, said:

Pain is the most common symptom of Paget’s disease but the reason that it occurs isn’t well understood. Although drugs called bisphosphonates are the standard treatment for pain in Paget’s, we know that in many patients they don’t work all that well. This new research gives some insights into why that may occur. Although further research is needed, we speculate that changes in bone shape or blood flow associated with PDB alter perception of sensory signals locally, or even in the spinal cord or brain, and influence the perception of pain.

This may have implications for the treatment of PDB using medicines that are available to target these pathways which could be used with – or even instead of – bisphosphonates on people with PDB suffering from pain.

Read the full paper.

Watch a series of video interviews on the Paget’s Association’s website.

 

Share

Leave a reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

css.php

Report this page

To report inappropriate content on this page, please use the form below. Upon receiving your report, we will be in touch as per the Take Down Policy of the service.

Please note that personal data collected through this form is used and stored for the purposes of processing this report and communication with you.

If you are unable to report a concern about content via this form please contact the Service Owner.

Please enter an email address you wish to be contacted on. Please describe the unacceptable content in sufficient detail to allow us to locate it, and why you consider it to be unacceptable.
By submitting this report, you accept that it is accurate and that fraudulent or nuisance complaints may result in action by the University.

  Cancel